This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2009-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2010
Title: Gerhard Gross: Innovator in Pharmaceutical Science
Introduction
Gerhard Gross is a notable inventor based in Lörrach, Germany. He has made significant contributions to the field of pharmaceutical science, particularly in the development of methods to enhance drug bioavailability. With a total of 2 patents to his name, Gross continues to impact the industry through his innovative approaches.
Latest Patents
One of his latest patents is focused on "Methods for improving bioavailability of a renin inhibitor." This invention provides a method for enhancing the bioavailability of a renin inhibitor, specifically a δ-amino-γ-hydroxy-ω-aryl-alkanoic acid derivative. The method involves co-administering a combination of the renin inhibitor and an efflux protein inhibitor to a mammal, particularly a human, in need of such treatment.
Another significant patent is for "N-oxides of N-phenyl-2-pyrimidine-amine derivatives." This invention relates to N-phenyl-2-pyrimidine-amine derivatives where at least one nitrogen atom carries an oxygen atom, forming the corresponding N-oxides. It includes processes for their preparation, pharmaceutical compositions containing these compounds, and their therapeutic applications for warm-blooded animals, including humans.
Career Highlights
Gerhard Gross is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative solutions that address critical health challenges. His expertise in pharmaceutical sciences has positioned him as a valuable asset in the research and development sector.
Collaborations
Throughout his career, Gross has collaborated with esteemed colleagues such as Gian P. Camenisch and Isabel Ottinger. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of pharmaceutical research.
Conclusion
Gerhard Gross exemplifies the spirit of innovation in the pharmaceutical industry. His patents and contributions continue to pave the way for advancements in drug development and therapeutic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile